SCHEMBL23974128

SCHEMBL23974128

CCCCOc1ccc(/C(C)=N/NC(=O)CC(C)(C)SSc2ccccn2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.46
▸ ALDH1A1 P00352 5/20 0.46
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ LMNA P02545 4/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ POLB P06746 2/20 0.45
▸ SMN1; SMN2 Q16637 5/20 0.44
▸ HTT P42858 2/20 0.44
▸ HPGD P15428 2/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ GAA P10253 3/20 0.40
▸ MITF O75030 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ TP53 P04637 1/20 0.39
▸ RAD52 P43351 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18519259 0.85 ALDH1A1 (0.39) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL23187335 0.82 MAPT (0.37) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL12665038 0.79 ALDH1A1 (0.47) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL12665045 0.78 MAPT (0.46) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL16018268 0.78 LMNA (0.45) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL12673743 0.77 MAPT (0.46) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL16016651 0.76 LMNA (0.45) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL19733500 0.75 MAPT (0.47) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL14616551 0.75 LMNA (0.47) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL15290549 0.74 LMNA (0.46) MAPTALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023066314-A1 BICYCLIC PEPTIDE LIGAND FOR NECTIN-4 AND USE THEREOF 海思科医药集团股份有限公司 2023-04-27 — — WO disclosed
EP-3903825-A1 BI-LIGAND DRUG CONJUGATE AND USE THEREOF Coherent Biopharma (Suzhou), Limited (CN) 2021-11-03 — — EP disclosed
Send feedback